BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin TF, Hsu PI. Second-line rescue treatment of Helicobacter pylori infection: Where are we now? World J Gastroenterol 2018; 24(40): 4548-4553 [PMID: 30386104 DOI: 10.3748/wjg.v24.i40.4548]
URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4548.htm
Number Citing Articles
1
Amy B. Howell, Li-Shu Wang. Potential of cranberry for suppressing Helicobacter pylori, a risk factor for gastric cancerJournal of Berry Research 2020; 10(1): 11 doi: 10.3233/JBR-180375
2
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based StudyAntibiotics 2021; 10(10): 1242 doi: 10.3390/antibiotics10101242
3
Najmeh Salehi, Bahareh Attaran, Negin Eskini, Maryam Esmaeili, Atefeh Sharifirad, Mehdi Sadeghi, Marjan Mohammadi. New insights into resistance ofHelicobacter pyloriagainst third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutationsHelicobacter 2019; 24(5) doi: 10.1111/hel.12628
4
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial Journal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
5
Sho Suzuki, Mitsuru Esaki, Chika Kusano, Hisatomo Ikehara, Takuji Gotoda. Development of <i>Helicobacter pylori</i> treatment: How do we manage antimicrobial resistance?World Journal of Gastroenterology 2019; 25(16): 1907-1912 doi: 10.3748/wjg.v25.i16.1907
6
Ji Yong Hwang, Changho Kim, Yong Hwan Kwon, Ji Eun Lee, Seong Woo Jeon, Su Youn Nam, An Na Seo, Man-Hoon Han, Ji Hye Park. Dual Clarithromycin and Metronidazole Resistance Is the Main Cause of Failure in Ultimate <b><i>Helicobacter pylori</i></b> EradicationDigestive Diseases 2021; 39(5): 451 doi: 10.1159/000514278
7
Thaís da Silva Moraes, Lucas Kozoski de Lima, Rodrigo Cássio Sola Veneziani, Sérgio Ricardo Ambrósio, Raquel Alves dos Santos, Jonas Joaquim Mangabeira da Silva, Gustavo Lima Ribeiro, Jairo Kenupp Bastos, Carlos Henrique Gomes Martins. In vitro Antibacterial Potential of the Oleoresin, Leaf Crude Hydroalcoholic Extracts and Isolated Compounds of the Copaifera spp. Against Helicobacter pyloriJournal of Biologically Active Products from Nature 2021; 11(2): 183 doi: 10.1080/22311866.2021.1914730
8
D. Mark Pritchard, Jan Bornschein, Ian Beales, Ariel Beresniak, Hocine Salhi, Peter Malfertheiner. Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UKBMJ Open Gastroenterology 2021; 8(1): e000685 doi: 10.1136/bmjgast-2021-000685
9
Dina A. Gawad, Mai M. Elnaggar, Tarek S. Belal. Multi-analyte HPLC–DAD Method for Concurrent Analysis of Six Antimicrobials and Three Proton Pump Inhibitors Frequently used in Management of Helicobacter pylori Infection: Application to Simulated Intestinal Fluid SamplesChromatographia 2022;  doi: 10.1007/s10337-022-04168-6
10
Youn I Choi, Jun Won Chung, Dong Kyun Park, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Ja Young Seo. Tailored eradication <i>vs</i> empirical bismuth-containing quadruple therapy for first-line <i>Helicobacter pylori</i> eradication: A comparative, open trialWorld Journal of Gastroenterology 2019; 25(46): 6743-6751 doi: 10.3748/wjg.v25.i46.6743
11
Najmeh Salehi, Bahareh Attaran, Fatemeh Zare‐Mirakabad, Bahareh Ghadiri, Maryam Esmaeili, Mohadeseh Shakaram, Mohammad Tashakoripour, Mahmoud Eshagh Hosseini, Marjan Mohammadi. The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains Helicobacter 2020; 25(6) doi: 10.1111/hel.12731
12
Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yan‐Hua Chen, Sheng‐Yeh Tang, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, I‐Ting Wu, Chang‐Bih Shie, Seng‐Kee Chuah, Deng‐Chyang Wu. Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection Helicobacter 2021; 26(5) doi: 10.1111/hel.12840
13
Fan Zhang, Cong Chen, Jike Hu, Ruiliang Su, Junqiang Zhang, Zhijian Han, Hao Chen, Yumin Li. Molecular mechanism of Helicobacter�pylori‑induced autophagy in gastric cancer (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.10976
14
Irena Mladenova. Clinical Relevance of Helicobacter pylori InfectionJournal of Clinical Medicine 2021; 10(16): 3473 doi: 10.3390/jcm10163473
15
Paula Roszczenko-Jasińska, Marta Ilona Wojtyś, Elżbieta K. Jagusztyn-Krynicka. Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targetsApplied Microbiology and Biotechnology 2020; 104(23): 9891 doi: 10.1007/s00253-020-10945-w
16
Xiao-Jian He, Xiang-Peng Zeng, Chuan-Shen Jiang, Gang Liu, Da-Zhou Li, Wen Wang. Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in ChinaDigestive Diseases and Sciences 2022; 67(1): 208 doi: 10.1007/s10620-021-06856-z